Carbamazepine and lithium: different profiles in affective disorder? 1985

B Lerer, and N Moore, and E Meyendorff, and S R Cho, and S Gershon

UI MeSH Term Description Entries
D008094 Lithium An element in the alkali metals family. It has the atomic symbol Li, atomic number 3, and atomic weight [6.938; 6.997]. Salts of lithium are used in treating BIPOLAR DISORDER. Lithium-7,Lithium 7
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002220 Carbamazepine A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties. Amizepine,Carbamazepine Acetate,Carbamazepine Anhydrous,Carbamazepine Dihydrate,Carbamazepine Hydrochloride,Carbamazepine L-Tartrate (4:1),Carbamazepine Phosphate,Carbamazepine Sulfate (2:1),Carbazepin,Epitol,Finlepsin,Neurotol,Tegretol
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005059 Euphoria An exaggerated feeling of physical and emotional well-being not consonant with apparent stimuli or events; usually of psychologic origin, but also seen in organic brain disease and toxic states. Euphorias
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000341 Affective Disorders, Psychotic Disorders in which the essential feature is a severe disturbance in mood (depression, anxiety, elation, and excitement) accompanied by psychotic symptoms such as delusions, hallucinations, gross impairment in reality testing, etc. Depression, Reactive, Psychotic,Mood Disorders, Psychotic,Psychoses, Affective,Psychotic Affective Disorders,Psychotic Mood Disorders,Affective Disorder, Psychotic,Affective Psychoses,Disorder, Psychotic Affective,Disorders, Psychotic Affective,Mood Disorder, Psychotic,Psychotic Affective Disorder,Psychotic Mood Disorder
D001714 Bipolar Disorder A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence. Affective Psychosis, Bipolar,Bipolar Disorder Type 1,Bipolar Disorder Type 2,Bipolar Mood Disorder,Depression, Bipolar,Manic Depression,Manic Disorder,Manic-Depressive Psychosis,Psychosis, Manic-Depressive,Type 1 Bipolar Disorder,Type 2 Bipolar Disorder,Psychoses, Manic-Depressive,Bipolar Affective Psychosis,Bipolar Depression,Bipolar Disorders,Bipolar Mood Disorders,Depression, Manic,Depressions, Manic,Disorder, Bipolar,Disorder, Bipolar Mood,Disorder, Manic,Manic Depressive Psychosis,Manic Disorders,Mood Disorder, Bipolar,Psychoses, Bipolar Affective,Psychoses, Manic Depressive,Psychosis, Bipolar Affective,Psychosis, Manic Depressive

Related Publications

B Lerer, and N Moore, and E Meyendorff, and S R Cho, and S Gershon
September 1991, The American journal of psychiatry,
B Lerer, and N Moore, and E Meyendorff, and S R Cho, and S Gershon
February 1992, Acta psychiatrica Scandinavica,
B Lerer, and N Moore, and E Meyendorff, and S R Cho, and S Gershon
July 1992, Progress in neuro-psychopharmacology & biological psychiatry,
B Lerer, and N Moore, and E Meyendorff, and S R Cho, and S Gershon
December 1988, Journal of clinical psychopharmacology,
B Lerer, and N Moore, and E Meyendorff, and S R Cho, and S Gershon
November 1989, Lancet (London, England),
B Lerer, and N Moore, and E Meyendorff, and S R Cho, and S Gershon
September 2000, Acta neuropsychiatrica,
B Lerer, and N Moore, and E Meyendorff, and S R Cho, and S Gershon
January 1993, Neuropsychobiology,
B Lerer, and N Moore, and E Meyendorff, and S R Cho, and S Gershon
January 1982, Indian journal of psychiatry,
B Lerer, and N Moore, and E Meyendorff, and S R Cho, and S Gershon
March 1988, The American journal of psychiatry,
B Lerer, and N Moore, and E Meyendorff, and S R Cho, and S Gershon
April 1988, International clinical psychopharmacology,
Copied contents to your clipboard!